Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer

Name: Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer
License: Public Domain

Shaare Zedek Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 467570
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.